| Name | Title | Contact Details |
|---|---|---|
Caitlin Beck |
Marketing Director | Profile |
Maura Banks |
Associate Director, AURYXIA Marketing | Profile |
Geraldine Peters-Wiles |
VP, People Total Rewards and Operations | Profile |
Karen Tubridy |
Senior Vice President and Chief Development Officer | Profile |
Graham Ray |
Vice President of Sales | Profile |
MeMed is a host response, med-tech & bioconvergence company, offering innovative diagnostic host response tests that address complex clinical dilemmas & improve patient outcomes.
Specialty Flooring Systems Inc is a South Amboy, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Promosome is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Relay has developed a proprietary software solution for stakeholders of the biopharmaceutical technology licensing and development process.
Spring Bank Pharmaceuticals (NASDAQ: SBPH) is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using our proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. SMNH compounds are small segments of nucleic acids that the company designs to selectively target and modulate the activity of specific proteins implicated in various disease states. Spring Bank is developing its most advanced SMNH product candidate, inarigivir soproxil (formerly referred to as SB 9200), for the treatment of viral diseases, including hepatitis B virus (HBV), and other SMNH product candidates, including SB 11285, the company`s lead immunotherapeutic agent for the treatment of selected cancers through the activation of the STimulator of Interferon Genes, or STING, pathway.